Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by fringelifeon May 06, 2017 9:42pm
56 Views
Post# 26213176

RE:RE:RE:RE:Patients waiting months for approval to grow their own canna

RE:RE:RE:RE:Patients waiting months for approval to grow their own cannaNo I was referring to last quarter remember we were debating on what next quarters numbers will be. Last quarter numbers were around 2007 with approval to grow, so 3000 would be 50% growth from that. I'm only going by the 2500 as of mid-Feb would be halfway through quarter, so if same growth rate continues it will land roughly around 3000 by end of quarter (Mar 31st). It appears it certainly slowed down from 1000% growth from last quarter, but the article seems to suggest it's due to a backlog rather than lack of interest.  Also you suggested that the 1.5% would maintain, but 3000 would put it closer to 2%, so there was some growth although less than I expected. According to the article though, interest among patients is about 25% (when it states a 1/4 of patients have requested it), so if even half of those interested get approval that could put us up over 10% of patients once the government gets through the backlog.

DiligentSon wrote: Believe it or not, I do tire of being the voice of reason because it comes across negative and I don't mean to be the bad guy...I really don't get paid to talk shyt about THC, but I like math. An increase from 2500 to 3000 is only 20%. Unless youre referring to different stats..? Still, 20% is substantial growth.


Bullboard Posts